Zobrazeno 1 - 10
of 286
pro vyhledávání: '"David R Kaufman"'
Publikováno v:
Journal of Medical Internet Research, Vol 23, Iss 12, p e30323 (2021)
BackgroundThe rapidly evolving digital environment of the social media era has increased the reach of both quality health information and misinformation. Platforms such as YouTube enable easy sharing of attractive, if not always evidence-based, video
Externí odkaz:
https://doaj.org/article/4968c65ebf8441a5bc67f297634b3815
Publikováno v:
Vaccines, Vol 11, Iss 1, p 94 (2022)
The development of COVID-19 vaccines is a major scientific accomplishment that has armed communities worldwide with powerful epidemic control tools. Yet, COVID-19 vaccination efforts in the US have been marred by persistent vaccine hesitancy. We used
Externí odkaz:
https://doaj.org/article/c16e287da98748268949a653a0aaa127
Autor:
Elkin, Peter L.
Publikováno v:
In Journal of Biomedical Informatics February 2016 59:316-316
Autor:
Lisa H. Butterfield, Mary L. Disis, Bernard A. Fox, David R. Kaufman, Samir N. Khleif, Ena Wang, on behalf of the Society for Immunotherapy of Cancer Immuno-Oncology Biomarkers: State of the Art workshop speakers
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-13 (2018)
Abstract Identification of biomarkers in cancer immunotherapy that predict therapeutic response and/or limit adverse events are a critical need in the field. To address recent progress and hurdles around cancer biomarker development and utilization,
Externí odkaz:
https://doaj.org/article/74b8eea006a346f5a4830396f0b56bb7
Autor:
Miller, Randolph A.
Publikováno v:
In Journal of Biomedical Informatics June 2014 49:9-10
Autor:
Andrey Loboda, David R. Kaufman, Jonathan D. Cheng, Eric Rubin, Rodolfo Perini, Terrill K. McClanahan, Razvan Cristescu, Michael Nebozhyn, Mark Ayers
Supplementary Tables S1, S2; Supplementary Figures S1, S2, S3, S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bcc74b79737fc4aebcc7bdefb4455f6
https://doi.org/10.1158/1078-0432.22472192.v1
https://doi.org/10.1158/1078-0432.22472192.v1
Autor:
Andrey Loboda, David R. Kaufman, Jonathan D. Cheng, Eric Rubin, Rodolfo Perini, Terrill K. McClanahan, Razvan Cristescu, Michael Nebozhyn, Mark Ayers
Purpose:Molecular profiling of large databases of human tumor gene expression profiles offers novel opportunities for informing decisions in clinical development programs.Experimental Design:Gene expression profile of programmed death ligand 1 (PD-L1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d589389a7eacf0413cc1115944af14b
https://doi.org/10.1158/1078-0432.c.6528152.v1
https://doi.org/10.1158/1078-0432.c.6528152.v1
Publikováno v:
Knowledge Management & E-Learning: An International Journal, Vol 7, Iss 4, Pp 550-575 (2015)
Background: Consumer eHealth tools play an increasingly important role in engaging patients as participants in managing their health and seeking health information. However, there is a documented gap between the skill and knowledge demands of eHealth
Externí odkaz:
https://doaj.org/article/379824d0cca648e3b17c7cd6e79a99a6
Publikováno v:
Proceedings of the Twentieth Annual Conference of the Cognitive Science Society ISBN: 9781315782416
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ff1b27d307f699e8849b038c367036d
https://doi.org/10.4324/9781315782416-10
https://doi.org/10.4324/9781315782416-10
Autor:
Matthew M. Burton, Timothy A. Miksch, Bradley N. Doebbeling, Adela Grando, Stepahanie Furniss, David R. Kaufman, Karl A. Poterack, Richard A. Helmers
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 3, Iss 3, Pp 319-326 (2019)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 3, Iss 3, Pp 319-326 (2019)
Objective To systematically examine clinical workflows before and after a major electronic health record (EHR) implementation, we performed this study. EHR implementation and/or conversion are associated with many challenges, which are barriers to op